×

Actavis CEO: Allergan best run pharma company

9:30 AM ET Mon, 17 Nov 2014

CNBC's David Faber speaks to David Pyott, Allergan chairman & CEO, and Brent Saunders, Actavis CEO about their deal worth roughly $66 billion and what it means for shareholders.